Status:
COMPLETED
Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
HIV Infections
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
This study examined the effects of two commonly prescribed HIV drugs on the way the body metabolizes glucose, insulin and fat.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy volunteers
Exclusion
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00135434
Start Date
September 1 2004
End Date
June 1 2005
Last Update
April 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Pharmacology Unit, Bristol-Myers Squibb Company
Hamilton, New Jersey, United States, 08690